PMID: 9163595May 1, 1997Paper

A phenylalanine-55 to serine amino-acid substitution in the human glycoprotein IX leucine-rich repeat is associated with Bernard-Soulier syndrome

British Journal of Haematology
P NorisA E von dem Borne

Abstract

The platelet membrane glycoprotein (GP) Ib-IX-V complex, the major von Willebrand factor receptor on platelets, is absent or dysfunctional in patients with the Bernard-Soulier syndrome (BSS). The four single subunits of the GPIb-IX-V complex (GPIb alpha, Ib beta, IX and V) are molecular products of different genes. Several point mutations and deletions affecting the GPIb alpha gene have been identified as the cause of BSS, whilst in four BSS families a GPIX gene defect has been reported. Moreover, a single case of BSS has been associated with a genetic defect of GPIb beta. We investigated the molecular basis of another case of BSS with a deficient expression of GPIX, as detected by immunofluorescence studies. After amplification of the entire GPIX coding region, nucleotide sequence analysis showed a homozygous single point mutation predicting a phenylalanine to serine substitution at position 55 of the mature GPIX within its unique leucine-rich repeat. By allele-specific oligonucleotide hybridization we confirmed the homozygosity of the patient as well as the carrier state of two out of three of his children studied. Although the parents of the patient, who were first cousins, were no longer alive and thus not available for stu...Continue Reading

Citations

Dec 5, 2002·International Journal of Hematology·Shinji KunishimaHidehiko Saito
Jan 22, 2004·Critical Reviews in Oncology/hematology·Indra Ramasamy
Dec 3, 1999·British Journal of Haematology·S KunishimaH Saito
Jun 18, 2014·Human Mutation·Anna SavoiaFrancois Lanza
Dec 12, 2018·Protein and Peptide Letters·Norio MatsushimaRobert H Kretsinger
Apr 11, 2018·Clinical Case Reports·Imtinan K AlsahafiGhaida B Alahmadi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.